The Pharmaceutical Law section of the Madrid Bar Association (ICAM) organized a webinar to analyze the four years of validity of the new Public Sector Contracts Law (LCSP), the peculiarities of its application in the pharmaceutical sector and the challenges that they must be faced in order to evolve towards a value-based purchase, which includes biosimilar medicines.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
